Related Experiment Video
Updated: Aug 29, 2025

12:18
A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment
Published on: January 11, 2020
7.6K
Multiple Cost Optimisation for Alzheimer's Disease Diagnosis
Summary
This study introduces a new algorithm for dementia diagnosis that considers budget constraints like time and money. It helps create more practical and cost-effective diagnostic tools for healthcare professionals.
Area of Science:
- Artificial Intelligence
- Medical Informatics
- Machine Learning
Background:
- Current machine learning models for dementia diagnosis often overlook practical constraints such as assessment time and financial costs.
- Optimizing dementia care pathways requires addressing multiple, non-fungible budget limitations faced by stakeholders.
Purpose of the Study:
- To develop a generalized cost-sensitive feature selection approach for dementia diagnosis that accounts for multiple budget constraints.
- To introduce an optimization algorithm capable of searching cost-weighting hyperparameters under total budget limitations.
Main Methods:
- Developed a novel optimization algorithm for cost-sensitive feature selection with multiple budget constraints.
- Implemented and validated the framework using assessment time and financial budget costs.
- Created a user-friendly graphical user interface (GUI) sandbox tool for a humans-in-the-loop approach.
Main Results:
- Budget constraints effectively controlled the feature selection process in a practical manner.
- Adjusting cost-weighting hyperparameters expanded the range of selected features.
- The GUI tool facilitated adoption and exploration by non-technical users.
Conclusions:
- Setting initial budget constraints and fine-tuning cost-weighting hyperparameters is an effective strategy for feature selection with multiple cost considerations.
- This approach enables more realistic optimization and redesign of dementia diagnostic assessments.
- The framework supports the development of predictive yet practical dementia diagnostic tools suitable for clinical implementation.
Related Concept Videos
Alzheimer's Disease: Treatment
249
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
249
Alzheimer's Disease: Overview
644
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
644

